MedTrace Logo

Prospective Study of Induction Medications Used in the Trauma RSI

NCT04291521 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2026-05-04

No results posted yet for this study

Summary

To compare the outcomes of the use of propofol, etomidate, and ketamine as induction agents for adult trauma patients undergoing intubation within 24 hours of admission. The primary goal is to determine the ideal agent that should be used in this patient population for intubations.

Conditions

  • Trauma
  • Rapid Sequence Intubation

Interventions

DRUG

Ketamine

Administering ketamine as an induction medication for intubating adult trauma patients within 24 hours of hospital admission.

DRUG

Etomidate

Administering etomidate as an induction medication for intubating adult trauma patients within 24 hours of hospital admission.

DRUG

Propofol

Administering propofol as an induction medication for intubating adult trauma patients within 24 hours of hospital admission.

Sponsors & Collaborators

  • University of California, Irvine

    collaborator OTHER

  • University of Texas

    collaborator OTHER

  • University of Chicago

    collaborator OTHER

  • Medical College of Wisconsin

    collaborator OTHER

  • University of Southern California

    lead OTHER

Principal Investigators

  • Catherine M Kuza, MD · Keck School of Medicine of the University of Southern California

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2027-01-01
Primary Completion
2029-04-30
Completion
2029-07-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04291521 on ClinicalTrials.gov